Cargando…
PReS-FINAL-2185: Prognostic markers in juvenile vs. adult-onset ankylosing spondylitis
Autores principales: | Jadon, D, Hunt, LP, Arumugam, R, Ramanan, AV, Sengupta, R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044577/ http://dx.doi.org/10.1186/1546-0096-11-S2-O20 |
Ejemplares similares
-
PReS-FINAL-2001: The impact of adalimumab on growth in patients with juvenile idiopathic arthritis
por: Ruperto, N, et al.
Publicado: (2013) -
PReS-FINAL-2168: Comparison of safety and retention rate of TNF antagonist therapy in juvenile-onset and adult-onset ankylosing spondylitis: data from the spanish registry biobadaser 2.0
por: Sifuentes Giraldo, WA, et al.
Publicado: (2013) -
PReS-FINAL-2184: A randomized trial in new onset juvenile dermatomyositis: prednisone versus prednisone plus cyclosporine versus prednisone plus methotrexate
por: Ruperto, N, et al.
Publicado: (2013) -
PReS-FINAL-1020: Dysregulation of the peripheral blood D cell compartment is associated with disease activity in juvenile dermatomyositis
por: Piper, C, et al.
Publicado: (2013) -
PReS-FINAL-2060: The role of stress factors in the onset of juvenile idiopathic arthritis
por: Stepanenko, N, et al.
Publicado: (2013)